International Journal of Laboratory Hematology
Overview
The International Journal of Laboratory Hematology is a peer-reviewed publication dedicated to advancing the field of laboratory hematology. It provides a platform for researchers, clinicians, and laboratory professionals to share their latest findings, innovations, and best practices in the diagnosis, monitoring, and treatment of hematological disorders. The journal covers a wide range of topics including hematology testing methods, quality assurance, hematological malignancies, transfusion medicine, and hematopoietic stem cell transplantation. With its rigorous scientific approach, the journ
Details
Details
Abbr.
Int J Lab Hematol
Start
2007
End
Continuing
Frequency
Bimonthly
p-ISSN
1751-5521
e-ISSN
1751-553X
Country
United Kingdom
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 5406
67
SJR / Ranks: 8128
555
CiteScore / Ranks: 6529
4.10
JIF / Ranks: 3481
3.0
Recent Articles
1.
Reilly-Stitt C, Jennings I, Kitchen S, Cahillane M, Saunders C, George C, et al.
Int J Lab Hematol
. 2025 Mar;
PMID: 40062514
Background: To achieve accreditation for ISO 15189, laboratories are required to either participate in EQA exercises or intra-laboratory comparisons to meet the standard. Light transmission aggregometry performed by laboratory scientists...
2.
Police P, Noikongdee P, Phojanasenee T, Chantkran W, Apipongrat D
Int J Lab Hematol
. 2025 Mar;
PMID: 40059415
Introduction: This study aimed to evaluate the analytical performance of the high-concentrated thrombin time-to-reptilase time (hcTT/RT) ratio as a novel assay to neutralize fibrinogen effects and improve accuracy in unfractionated...
3.
Qin C, Tong X, Su C, Zhou Z, Zheng D
Int J Lab Hematol
. 2025 Mar;
PMID: 40054851
Background: Acute myeloid leukemia (AML) is a prevalent and potentially fatal hematologic malignancy with limited improvements in survival rates over the past few decades. ITGAM, encoding CD11b, is a significant...
4.
Moalosi G, Vaughan J, Schapkaitz E
Int J Lab Hematol
. 2025 Mar;
PMID: 40051119
Background: Limited availability of diagnostic tests in low-resource settings hampers the diagnosis and classification of diffuse large B-cell lymphoma (DLBCL). A study was performed to assess the use of resources...
5.
Onsongo S, Otieno K, Mathenge L, Makotsi E, Kariuki G, Ngetich V, et al.
Int J Lab Hematol
. 2025 Mar;
PMID: 40042316
Introduction: Malaria is a common and life-threatening infection. Malaria diagnosis needs to be fast and reliable. Although malaria microscopy is currently the gold standard, it is laborious, requires extensive training,...
6.
Anand K, Olteanu V, Zhang C, Nelton K, Aakre E, Botero J, et al.
Int J Lab Hematol
. 2025 Mar;
PMID: 40025642
Introduction: Von Willebrand factor (VWF) multimer analysis is essential for diagnosing and classifying von Willebrand disease (VWD) but requires expert interpretation and is subject to inter-rater variability. We developed an...
7.
Vimalathas G, Cedile O, Kjeldsen M, Thomassen M, Moller M, Nyvold C, et al.
Int J Lab Hematol
. 2025 Feb;
PMID: 40013464
Introduction: Formalin-fixed paraffin-embedded (FFPE) tumor biopsy is the current mainstay of genotyping, but is limited by its invasiveness and tumor heterogeneity. Plasma cell-free DNA (cfDNA) constitutes a minimally invasive alternative...
8.
Valerio Ikoma-Colturato M, Furtado F, de Oliveira E, Gevert F, Mendonca R
Int J Lab Hematol
. 2025 Feb;
PMID: 40007453
Introduction: Measurable residual disease (MRD) in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) following anti-CD19 targeted therapies requires specific strategies to identify residual blast cells due to loss or reduced CD19...
9.
Ahmed Y, El-Khazragy N, Haroun R, Fathy S
Int J Lab Hematol
. 2025 Feb;
PMID: 40001305
Background: Long noncoding RNAs (lncRNAs) have emerged as key regulators of cancer; in addition, they have been identified as novel therapeutic targets and biomarkers for several cancers, including diffuse large...
10.
Ilyasova K, Zerkalenkova E, Soldatkina O, Kazakova A, Myakova N, Roumiantseva J, et al.
Int J Lab Hematol
. 2025 Feb;
PMID: 40000924
Background/objectives: Infant BCP-ALL is classified into KMT2A-r and KMT2A-wt groups, both showing heterogeneity. KMT2A rearrangements indicate poor prognosis, but outcomes vary by fusion partner. The KMT2A-wt group includes cases in...